MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore Microcephalic Osteodysplastic Dysplasia Saul-Wilson type, its diagnosis through genetic testing, family planning implications, and personalized treatment options.
Explore the impact of genetic testing in diagnosing and managing Morquio Syndrome. Learn about personalized treatments and family planning advancements today.
Explore how genetic testing, including whole genome sequencing, transforms Mucopolysaccharidosis (MPS) diagnosis, treatment, and family planning strategies.
Explore how genetic testing transforms multiminicore myopathy diagnosis, revealing genetic mutations, enabling early interventions, and guiding personalized treatments.
Explore how exome sequencing revolutionizes the diagnosis of Multiple Congenital Anomalies/Dysmorphic Syndrome, enhancing precision medicine and personalized care.
Explore how genetic testing aids in early detection and management of Multiple Endocrine Neoplasia Type 2, focusing on RET mutations and personalized treatment plans.
Explore how genetic testing aids in diagnosing Muscle Eye Brain Disease, a rare genetic disorder, facilitating early intervention and personalized treatment strategies.
Genetic testing revolutionizes Myelodysplastic Syndrome care by enabling early diagnosis, personalized treatment, risk stratification, and monitoring disease progression.